Effect of high dose atorvastatin within 24 hours before elective percutaneous coronary intervention on periprocedural myocardial infarction in patients treated at Imam Khomeini hospital between September 2010 to March 2011 -

Trial Profile

Effect of high dose atorvastatin within 24 hours before elective percutaneous coronary intervention on periprocedural myocardial infarction in patients treated at Imam Khomeini hospital between September 2010 to March 2011 -

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Angina pectoris; Coronary disorders; Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top